Genomic & Biopharma News

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
ORB Company News, 2016-12-28 18:58:47

As his wife’s caregiver, a doctor discovers what’s missing at health care’s core
Caring for someone with a serious illness stretches people spiritually and emotionally, often beyond what they might have thought possible.
News Medical Life Sciences, 2019-12-05 12:00:13

DNA testing for siblings of children with ASD may be predictive of future diagnosis
One of the key priorities of interventions for autism spectrum disorder (ASD) is starting early, with some evidence showing infants as young as seven months old could benefit.
News Medical Life Sciences, 2019-12-05 11:54:00

Aurinia soars as phase 3 lupus study hits primary endpoint
A phase 3 trial of Aurinia Pharmaceuticals’ voclosporin in lupus nephritis has hit its primary endpoint, causing the company's share price to double. The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.
Fierce Biotech, 2019-12-05 11:46:06

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests.
ORB Company News, 2016-12-28 18:58:47

California surprise-billing law protects patients but aggravates many doctors
More than two years after California's surprise-billing law took effect, there's one thing on which consumer advocates, doctors and insurers all agree: The law has been effective at protecting many people from bills they might have been saddled with from doctors who aren't in their insurance network.
News Medical Life Sciences, 2019-12-05 11:29:07

How worms revealed a key protein in insulin synthesis and diabetes
By studying the nematode Caenorhabditis elegans, scientists from Vanderbilt University and the University of Michigan have identified a protein that's key for insulin synthesis, the understanding of which they say could lead to new approaches to prevent and treat Type 2 diabetes and other diseases.
Fierce Biotech, 2019-12-05 10:12:42

INTCR 2020 Executive Steering Group Chair shares insight into this ever-growing competition
Flying the flag for clinical research for over 20 years, this competition continues to grow and develop year after year.
PharmaTimes, 2019-12-05 09:27:49

Late-stage Ibsrela success for Ardelyx
If approved, the drug will be the only non-binder treatment for the control of serum phosphorus in patients with CKD on dialysis.
PharmaTimes, 2019-12-05 09:18:25

EMA to review Amarin’s Vascepa filing
The fish oil-derived therapy is already approved in the US for patients with severe hypertriglyceridaemia.
PharmaTimes, 2019-12-05 09:14:13

Veeva announces CRM updates for 2020
The system gives users “greater flexibility” to customise the company's established CRM.
PharmaTimes, 2019-12-05 09:12:07